Tempus AI, Inc.

NasdaqGS:TEM Stock Report

Market Cap: US$7.6b

Tempus AI Balance Sheet Health

Financial Health criteria checks 2/6

Tempus AI has a total shareholder equity of $491.3M and total debt of $1.2B, which brings its debt-to-equity ratio to 252.3%. Its total assets and total liabilities are $2.3B and $1.8B respectively.

Key information

252.28%

Debt to equity ratio

US$1.24b

Debt

Interest coverage ration/a
CashUS$755.00m
EquityUS$491.33m
Total liabilitiesUS$1.78b
Total assetsUS$2.27b

Recent financial health updates

No updates

Recent updates

Heavy AI Infrastructure And Rising Costs Will Pressure Data Economics Yet Eventually Support Upside

Catalysts About Tempus AI Tempus AI provides AI driven molecular diagnostics and data products to support clinical decision making and drug development. What are the underlying business or industry changes driving this perspective?

Tempus AI: No AI Interruption Detected

Feb 25

Genomics And AI Data Licensing Will Transform Long Term Oncology Outcomes

Catalysts About Tempus AI Tempus AI operates a genomics and data platform focused on Oncology and related clinical insights. What are the underlying business or industry changes driving this perspective?

After Leaping 29% Tempus AI, Inc. (NASDAQ:TEM) Shares Are Not Flying Under The Radar

Oct 09
After Leaping 29% Tempus AI, Inc. (NASDAQ:TEM) Shares Are Not Flying Under The Radar

Tempus AI, Inc. (NASDAQ:TEM) Looks Just Right With A 28% Price Jump

Aug 15
Tempus AI, Inc. (NASDAQ:TEM) Looks Just Right With A 28% Price Jump
User avatar

AstraZeneca And Pathos Partnership Will Expand Precision Medicine

Pharma partnerships and the shift toward AI-driven precision medicine are fueling strong, high-margin revenue growth and expanding Tempus' competitive opportunities.

The Tempus AI, Inc. (NASDAQ:TEM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Tempus AI, Inc. (NASDAQ:TEM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Tempus: The AI Engine Powering Healthcare

Apr 20

Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now

Mar 25

Tempus AI: The Investment Opportunity Of A Decade, Strong Buy

Mar 18

Tempus AI Earnings: A Promising Business, But There Are Risks

Feb 25

Tempus AI Is A Buy On Dips In The AI-Driven Healthcare Sector

Feb 18

Tempus AI: In Vogue, But Better To Wait For Some Retracement

Feb 05

Tempus AI: Don't Be Blindly Optimistic On Anything AI

Jan 28

Tempus AI: Why I'm Avoiding This Stock In 2025

Jan 21

Financial Position Analysis

Short Term Liabilities: TEM's short term assets ($1.2B) exceed its short term liabilities ($372.4M).

Long Term Liabilities: TEM's short term assets ($1.2B) do not cover its long term liabilities ($1.4B).


Debt to Equity History and Analysis

Debt Level: TEM's net debt to equity ratio (98.6%) is considered high.

Reducing Debt: TEM's debt to equity ratio has increased from 72.2% to 252.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TEM has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TEM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/29 02:05
End of Day Share Price 2026/03/27 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tempus AI, Inc. is covered by 21 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Michael RyskinBofA Global Research
Mark MassaroBTIG